MEDVi vs PeterMD: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
MEDVi beats PeterMD overall, scoring 7.7/10 vs 7.3/10. PeterMD is more affordable at $165/mo vs $299/mo. Choose MEDVi for users who want a low entry price with oral and injectable co. Choose PeterMD for budget-conscious users looking for the lowest monthly glp-1 .
A side-by-side comparison of MEDVi and PeterMD covering pricing, scores, medication types, insurance, and more to help you decide.
MEDVi
#21 of 40Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
Visit MEDViPeterMD
#28 of 40One of the most affordable compounded GLP-1 options on the market, ideal for budget-conscious patients.
Visit PeterMD| Feature | MEDVi | PeterMD |
|---|---|---|
| Our Score | 7.7/10 | 7.3/10 |
| Starting Price | $299/mo | $165/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want a low entry price with oral and injectable compounded options | Budget-conscious users looking for the lowest monthly GLP-1 cost |
| Ranking | #21 | #28 |
Pros & Cons Compared
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
PeterMD
Pros
- +Flat $165/mo at all dose levels — price doesn't increase as you titrate up to maintenance doses
- +Semaglutide + B12 formulation helps reduce nausea — the most common GLP-1 side effect
- +100,000+ patient base with 4.9/5 Trustpilot rating from 14,000+ reviews — strong social proof
- +Video consultations with physicians included — real face-to-face medical oversight
Cons
- −Only available in 42 states — excluded from 8 states, limiting nationwide access
- −Not BBB accredited, with some documented complaints about delayed medication fulfillment
- −Originally a testosterone replacement therapy platform — GLP-1 is an expansion, not the core focus
Our Verdict
MEDVi edges out PeterMD with a score of 7.7/10 vs 7.3/10. If budget is your priority, PeterMD starts at $165/mo compared to MEDVi's $299/mo. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options. Choose PeterMD if you want: budget-conscious users looking for the lowest monthly glp-1 cost.